Companion Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1127 | Report Format : | Status : Upcoming |

Abstract

Global Companion Diagnostics Market: Overview

A diagnostic test used as an associate to the therapeutic drug in order to determine its usefulness to the patient is known as companion diagnostics. This technology is useful for improving therapeutic treatment available based on the individual. Companion diagnostics integrate pharmacogenomic information that will assist to make most optimal treatment decision possible for the patient. Companion diagnostic is an in-vitro medical device that is used to provide information necessary for effective and safe use of the corresponding drug. It will help healthcare professionals to determine whether therapeutic products benefit to patients or cause any side effects. It is gaining importance in the drug discovery and personalized treatment medicine. Companion diagnostic is also used to determine patient personal molecular profile to decide which therapy is useful for the patient. Companion diagnostics test finds the presence of a biomarker in the patient and its presence and absence will determine whether a patient will respond to the treatment or not.

Global Companion Diagnostics Market: Growth Factors

Escalating growth in the global companion diagnostics market is mainly due to technological development in the medical devices for the treatment and diagnosis of the patients. Increasing prevalence of diseases such as cancer & HIV is anticipated to foster the global market growth as it helps in determining patient-specific dose and drugs. Rising awareness among patients and physicians regarding drug toxicity is positively enhancing the global companion diagnostics market. Increasing population in the developing countries is expected to propel the global market growth. However, the major challenges before the global market are the lack of skilled professionals, lack of awareness about companion diagnostics, and logistic issues raised in order to develop drug and companion diagnostics together, which may hinder the global companion diagnostics market growth.

Global Companion Diagnostics Market: Segmentation

The global companion diagnostics market is divided based on the disease as gastric cancer, colorectal cancer, melanoma cancer, genital cancer, breast cancer, lung cancer, and others. On the basis of indications, the global market is segmented as inflammation, cardiovascular, virology, central nervous system, and oncology. Of these, oncology is the largest revenue-generating segment in the global companion diagnostics market.

Global Companion Diagnostics Market: Regional Analysis

The global companion diagnostics market is segmented based on geography as Europe, Asia Pacific, Latin America, North America, and the Middle East & Africa. North America contributed for the largest market chunk. Europe accounted for the largest market share in the global market owing to increasing incidence of cancer and other diseases. In addition, increasing healthcare awareness in this region also positively impacts the global companion diagnostics market.

Global Companion Diagnostics Market: Competitive Players

Major players denominating the global companion diagnostics market growth are Myriad Genetics, Qiagen, Life Technologies, Abbott, Thermo Fischer Scientific, and Genomic Health. Other players influencing the global market are Roche Holdings, Protagen Diagnostics, Amgen, Agilent Technologies, Myriad Genetics, and Sysmex.

Global Companion Diagnostics Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Vitreous Tamponades Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2539 | Report Format:

Global Vitreous Tamponades Market: Overview Vitreous tamponades are the postoperative devices utilized in the retinal detachment vitrectomy processes. Retinal detachment is extremely grave medical condition and if not taken care of on time, can result in eternal vision loss. Vitrectomy is a surg...Read More

Operating Room Equipment Market by Product (Anesthesia Devices, Endoscopes, Operating room Lights, Operating Tables, Electrosurgical Devices, Surgical Imaging Devices and Patient Monitors), For Hospitals, Outpatient Facilities and Ambulatory Surgical Centers: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2515 | Report Format:

The operating room equipment market report includes comprehensive and profound analysis on the global and regional level. The report gives historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study comprises drivers, restraints, and opportunities for th...Read More

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2511 | Report Format:

The report covers forecast and analysis for the Heart Valve Devices Market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the heart valve devices market ...Read More

Choose License Type:
Latest Published Reports

View All Published Reports